Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Wino115on Mar 28, 2022 10:27am
57 Views
Post# 34551756

RE:RE:RE:Delay in Phase 1 a --------Get over it

RE:RE:RE:Delay in Phase 1 a --------Get over it

I'm just guessing, but there's probably a way to fill out some paperwork and nominate someone for a Board seat.  You'd have to read up in their corporate bylaws or ask them.  I was hoping an institutional shareholder would put up a candidate or two.  If it's not an em0loyee of their firm, they wouldn't be insiders.  Was hoping Soleus might want a bit of representation there or seek to help them in skills they are deficient in from their perspective.  


Biobob wrote: So what's coming up this week new lows again... more silence... What happens if the whole borad is voted out... can we propose candidates, can we propose changes to management (CEO, CFO).  I would really like to have Wino to represent us and give us a better picture of our options and best path for the future of the company.  I still don't know if we are better off settling for whatever offer we ca take for the company vs dilution, borrowing for risky propjects and possibly failure down the road.  I mean while it's still worth something.

 

<< Previous
Bullboard Posts
Next >>